Bisphosphonates reduced complex regional pain syndrome pain intensity in the short term but not other time scales.
A new study suggests that medicines used to treat osteoporosis might help relieve pain in people with complex regional pain ...
Researchers found a small but greater risk of a hip fracture after 2 years of taking a "drug holiday" — stopping therapy — after long-term (≥ 3-year) use of one bisphosphonate, risedronate, versus ...
Please provide your email address to receive an email when new articles are posted on . Patients receiving long-term glucocorticoids should use oral bisphosphonates to reduce the risk for bone loss ...
SEATTLE -- Risk of death was lower in the years after a bisphosphonate was started following a fracture rather than denosumab (Prolia), a target trial emulation found. In adults ages 50 and older who ...
Boniva (ibandronate) is a brand-name oral tablet that’s prescribed to help prevent and treat osteoporosis. As with other drugs, Boniva can cause side effects, such as jaw or teeth problems. In rare ...
The American College of Physicians updated its 2017 guideline on pharmacologic treatment of osteoporosis or low bone mass to prevent fractures in adults. In a shift from previous recommendations, the ...
Data suggest a protective association of bisphosphonates against having a kidney stone diagnosis or procedure. Patients receiving bisphosphonates for osteoporosis treatment are less likely to have ...
A new study published on the preprint server medRxiv* examines the effect of bisphosphonates (BPs) on the outcome of coronavirus disease 2019 (COVID-19) in American patients during the first wave of ...
In advance of the anticipated effective date of the Horseracing Integrity and Safety Authority's (HISA) Anti-Doping and Medication Control (ADMC) Program on March 27, 2023, the Horseracing Integrity & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results